Q: Can I get retatrutide now
The existing pattern across the GLP-1 class is that the weight-loss curve is driven hardest during titration and the first several months at target dose, and that once the primary loss is achieved, maintenance becomes a separate problem with a different tolerability budget
The Science Supporting Our Approach Our protocols are directly informed by the latest clinical research, including the groundbreaking 2025 Galderma study that specifically examined facial volume loss in patients using GLP-1 medications
Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow
The participants in the studies were 43,522 with DPP-4 inhibitors, 60,080 with GLP-1RA, and 77,541 with SGLT-2 inhibitors, for a total number of 181,143 participants
Always use pharmaceutical-grade bacteriostatic water for reconstitution